BioSpace News Archive

Business

Supervisory Board of Epigenomics AG Appoints Dr. Jorge Garces as President and CSO

Dr. Garces will become a member of the Executive Board of Epigenomics and oversee Operations, Research and Development, Clinical Affairs, Regulatory and Quality.

November 6, 2017
·
3 min read
ICON Reveals Voice-Assistant Applications for Clinical Trials at ISPOR Annual European Congress

ICON will be demonstrating early work using the Amazon Echo Voice Assistant platform to enhance interactions with patients enrolled into clinical trials, at the ISPOR 20th Annual European Congress, Glasgow, Scotland on Wednesday 8th November 2017.

November 6, 2017
·
4 min read
Profound Medical Announces Expanded Clinical Use of TULSA-PRO in Prostate Care to Include BPH

The company announced that Benign Prostatic Hyperplasia treatments utilizing TULSA-PRO® are now being successfully conducted in Germany.

November 6, 2017
·
6 min read
Business

Eutilex and Huahai Enter Immuno-Oncology Partnership

Under the agreement, Huahai takes a $30M equity stake in Eutilex and receives an exclusive license to develop and commercialize EU-101.

November 6, 2017
·
5 min read
Biotech Bay

Omnicell Launches New IVX Workflow Solution to Enhance Safety, Accuracy, and Efficiency in Sterile Compounding

Massachusetts General Hospital and Brigham and Women’s Hospital have chosen to adopt this new technology.

November 6, 2017
·
4 min read
Drug Development

Alpine Immune Sciences Presents ALPN-101 Program Data Demonstrating Potent Preclinical Activity in Arthritis and Inflammation

Findings suggest molecules from the company’s vIgD platform could potentially have clinical therapeutic utility in multiple inflammatory diseases.

November 6, 2017
·
5 min read
Business

Translate Bio Appoints Ann Barbier, M.D., Ph.D., as Chief Medical Officer

Translate Bio today announced the appointment of Ann Barbier, M.D., Ph.D., as chief medical officer, effective immediately.

November 6, 2017
·
2 min read
Business

CytRx Announces Strategic Realignment of Clinical Development Team

Going forward, CytRx’s drug development, manufacturing and regulatory activities will be led by Hurley Consulting Associates Ltd.

November 6, 2017
·
3 min read
Drug Development

Concert Pharmaceuticals Announces Completion of Enrollment in First Cohort of CTP-543 Phase IIa Trial

The Phase 2a trial is expected to be completed in the second half of 2018.

November 6, 2017
·
5 min read
Drug Development

BriaCell Provides Clinical Update on its Lead Vaccine Candidate, BriaVax

The Phase I/IIa study evaluates the safety and activity of BriaVax in patients with advanced breast cancer. To boost the anti-tumor effects of BriaVax.

November 6, 2017
·
6 min read